SAN DIEGO, May 30 /PRNewswire/ -- BioDuro, LLC. (Privately held), a leading company in the business of life sciences outsourcing from the pharmaceutical and biotechnology industry with headquarters in San Diego, California and laboratory facilities in Beijing, China, announced today the recent appointment of Nigel R. A. Beeley, Ph.D., to the position of CEO, China Operations. Dr. Beeley is an internationally recognized biotechnology and pharmaceutical industry executive with more than twenty-five years of experience in drug discovery and development, including involvement in 15 projects that progressed molecules to the clinic, three of which have become marketed products.
Dr. Beeley obtained a BSc. Honours (Class 1) degree in chemistry from the University of Liverpool, UK followed by a Ph.D. from the University of Manchester, UK on prostaglandin synthesis (supervisor Prof. J.K. Sutherland). He then spent two years as a Royal Society Overseas Research Fellow in Prof. A. Eschenmoser's laboratory (ETH, Zurich, Switzerland) on the synthesis of macrolide antibiotics. His industrial career began at Reckitt and Coleman, Pharmaceuticals Division, UK, working on opiates followed by several years in the cardiovascular group of Synthelabo Recherche, Paris, France, working on ACE inhibitors, dopamine agonists and calcium antagonists. Returning to the UK in 1988, he joined Celltech as Head of Oncology-Chemistry, contributing in particular to programs on antibody targeting to tumour antigens and inhibitors of matrix metalloproteinases. In 1994 he became Senior Director of Chemistry at Amylin Pharmaceuticals, Inc., San Diego, USA, working on peptides and proteins related to amylin, leptin and exendin along with small molecule amylin antagonists, activators of mitochondrial uncoupling protein (UCPs) and anti-atherosclerotic compounds. From early 1999 to June 2004 he was Vice President and Chief Chemical Officer at Arena Pharmaceuticals, Inc. where he built two substantial teams totaling over 120 chemically oriented scientists working on known and orphan G-protein coupled receptors. From June 2004 to early 2007 he was Vice President, Discovery for Senomyx, Inc. where he was focused on the identification and optimization of ligands for G-protein coupled receptors and ion channels involved in taste.
"I joined BioDuro because their corporate objectives and business plan are very much more attractive than any other outsourcing company in China along with their ability to rapidly capture high growth areas of outsourcing such as fully functional medicinal chemistry projects and preclinical development projects, PK and drug safety evaluation," said Beeley.
"Nigel has a breadth of pharmaceutical and biotechnology experience which is unique for a single individual," said John V. Oyler, President and CEO. "He is an inventor on over 70 patents and is a co-author on numerous scientific publications. He also brings considerable managerial prowess having built and managed several highly productive teams of hundreds of people. In addition, he was an early player in the outsourcing of discovery services to Asia from the client perspective."
"During the past few months BioDuro has expanded its chemistry and biology capabilities to almost all aspects of the drug discovery and pre-clinical development process," noted Masood Tayebi, Chairman of the Company. "The addition of Nigel to BioDuro's senior management team will strengthen our position as a leader in life sciences outsourcing and will enable BioDuro to expand further the number of fully outsourced drug discovery and development programs that BioDuro is undertaking for its customers."
About BioDuro, LLC. (http://www.bioduro.com)
Bioduro is a leading, multi-national life sciences outsourcing company providing high quality, low cost research and development services with headquarters in San Diego, CA and laboratories in Beijing, China. In China BioDuro currently has a team of 230 and collaborates with the NICPBP (an 82 person safety evaluation center in Beijing). BioDuro has built a world-class, multi-national team with extensive US and European experience and is operating in one of the best equipped laboratories in China. BioDuro works with over 30 different companies including 8 of the top 12 pharmaceutical companies, and adheres to all aspects of international business and ethical standards.
BioDuro, LLCCONTACT: John V. Oyler or Masood Tayebi, 1-888-251-1697, info@bioduro.com,both of BioDuro, LLC
Web site: http://www.bioduro.com/
